Cormorant Capital

Cormorant Capital

Cormorant Capital

Technical.ly Philly

University City biotech firm Cabaletta Bio Inc. goes public in $74.8M IPO

PE HUB

VC-backed Cabaletta Bio begins trading on NASDAQ

Xconomy

Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More

PE HUB

Satsuma Pharmaceuticals goes public

Xconomy

BridgeBio Upsizes IPO to $348M, Topping Adaptive’s Wall Street Debut

MedCity News

BridgeBio files for $225M initial public offering

$299,200,000 Venture capital
PE HUB

BridgeBio Pharma racks up $299.2 mln

$50,000,000 Venture capital (Series B)
MedCity News , FinSMEs

Cabaletta Bio closes $50M Series B round for cell-based autoimmune disease therapies

Xconomy

BridgeBio Picks Up Novartis Cancer Drug, Launches New Biotech Startup

Health Science
Xconomy

BridgeBio Bags $135M For “Hub and Spoke” Rare Disease Drug R&D

Health Funding
$12,000,000 Venture capital (Series A)
PE Hub

Satsuma Pharmaceuticals takes in $12 mln Series A